Our Story
Committed to helping others achieve their healthiest future.
At Metavo, we believe we can help build healthier communities. We develop plant-based products that help people feel better, backed by the science that makes them feel confident.
Meet our founder
Our founder, Dr. Paul Spagnuolo, is a Professor in the Department of Food Science at the University of Guelph in Ontario, Canada. In his research on food-derived bioactive compounds, Dr. Spagnuolo used his lab’s drug discovery platform to screen thousands of molecules for activity. In 2012, he discovered the most active compound, Avocatin-B (AvoB™), a lipid found in a unique subset of avocados with powerful properties.
Dr. Spagnuolo originally discovered that AvoB™ could target and inhibit the survival of leukemia stem cells. The Ontario Institute for Cancer Research funded his work. It occurred to him that AvoB™ could target the same pathway in other disease states.
Healthier Bodies,
Healthier Future
Dr. Spagnuolo and his team want to help others achieve their healthiest future by sharing his discovery with the rest of the world. Like so many others, Dr. Spagnuolo has had family members and friends pass away from chronic diseases like cancer and diabetes. Knowing that prevention is the most effective way to reduce the human and economic cost of these diseases, we must do everything we can to improve and maintain our health. And that includes keeping stock of what we put into our bodies. Metavo is the first avocado-based supplement on the market that can help manage blood glucose levels and improve metabolism. *
Choose from our convenient capsules or mix for your daily does of Metavo.
One serving of Metavo a day offers just the right amount of BIOACTIVE AvoB™ to support a healthy metabolism and blood sugar levels in adults.*
Metavo Mix
Blend a scoop of Metavo with dairy alternatives, smoothies, milk or yogurt for your daily dose
SHOPDr. Spagnuolo’s Awards & Achievements
Dr. Paul Spagnuolo is an Associate Professor at the Department of Food Science, University of Guelph. His research focuses on novel nutraceuticals for the treatment of metabolic diseases. His research lab has discovered eight novel nutraceuticals, filed four patents, and completed two clinical trials. With an h-index of 19, his research is published in top journals, including Blood, Autophagy and Cancer Research and is supported by numerous agencies, including NSERC and CIHR. He is the editor of “Nutraceuticals and Human Health: The Food-to-supplement Paradigm,” a book published by the Royal Society of Chemistry, a member of the Avocado Nutrition Science Advisory Board, a member of the Editorial Board for the Journal of Natural Health Product Research and a co-founder of SP Nutraceuticals Inc. (Metavo). Source: Canadian Nutrition Society
OUR INGREDIENTSDr. Spagnuolo has received several national and international recognitions for his research contributions.
Young Investigator Award for Outstanding Research from the American Society for Nutrition April 2022
Young Investigator Award for Outstanding Research from the Canadian Nutrition Society (CNS) April 2021
International Award in Bioinnovation from the Luxembourg Institute of Science and Technology
Mead Johnson Award for Outstanding Research from the American Society for Nutrition 2016
Choose from our convenient capsules or mix for your daily does of Metavo.
